DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zometa (Zoledronic Acid) - Current Clinical Trials

 
 



Zometa Related Clinical Trials

Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older [Active, not recruiting]

Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer [Active, not recruiting]

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer [Recruiting]

ZOMETA« (Zoledronic Acid) for Prevention of Bone Metastases [Terminated]

Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis [Active, not recruiting]

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone [Completed]

Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year [Recruiting]

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer [Recruiting]

Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer [Not yet recruiting]

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients [Recruiting]

Re-treatment of Patients With Paget's Disease Using Zoledronic Acid [Recruiting]

Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers [Recruiting]

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis [Recruiting]

Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma [Terminated]

Zoledronic Acid in MS-patients With Osteoporosis [Recruiting]

Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-Menopausal Women With Low Bone Mass [Completed]

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer [Recruiting]

Double-Blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) [Active, not recruiting]

Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss [Recruiting]

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy [Recruiting]

Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients [Recruiting]

Effect of the Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Who Have Relapsed After 1-3 Prior Lines of Therapy [Recruiting]

Efficacy and Safety Study of ZOMETA« in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis [Recruiting]

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone [Active, not recruiting]

The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP) [Recruiting]

An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta [Recruiting]

Phase 1 Study of Zoledronic Acid in Sickle Cell Disease [Recruiting]

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms [Recruiting]

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer [Completed]

Zoledronate With Atorvastatin in Renal Cell Carcinoma [Active, not recruiting]

Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases [Recruiting]

Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer [Recruiting]

A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects [Active, not recruiting]

Zometa for the Management of Tumor-Induced Hypercalcemia and Malignant Bone Pain in the Community [Completed]

Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate [Active, not recruiting]

IV Zoledronic Acid After Forteo in Postmenopausal Women [Completed]

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Post Menopausal Women With Osteoporosis [Active, not recruiting]

Zoledronate in Treating Bone Marrow Micrometastases in Women With Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]

Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis [Completed]

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I [Active, not recruiting]

Zometa and Circulating VEGF in Breast Cancer Patients With Bone Metastasis [Recruiting]

Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy [Recruiting]

Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer [Active, not recruiting]

Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions [Terminated]

To Evaluate the Efficacy of ZOMETA« in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer [Recruiting]

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss [Recruiting]

Zoledronate and BMS-275291 in Treating Patients With Prostate Cancer [Active, not recruiting]

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer [Active, not recruiting]

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer [Not yet recruiting]

Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement [Recruiting]

Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients [Recruiting]

The Use of Zoledronic Acid to Prevent Cancer-Treatment Bone Loss in Post-Menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy [Recruiting]

The Use of Zoledronic Acid to Prevent Cancer-Treatment Bone Loss in Post-Menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

Open-Label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases

Open-Label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis [Active, not recruiting]

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer [Active, not recruiting]

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa«) in Patients With Breast Cancer [Completed]

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer [Recruiting]

Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-Related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis [Recruiting]

Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL) [Recruiting]

Feasibility of Doctors' Rooms-Based Infusion of Zoledronic Acid [Recruiting]

Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma [Completed]

Docetaxel and Carboplatin With or Without Zoledronate in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer [No longer recruiting]

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation [Recruiting]

Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee [Recruiting]

Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer [Recruiting]

A Prospective Multicentre Phase II Trial of Zoledronic Acid in Patients With Myelofibrosis With Myeloid Metaplasia (MMM) [Recruiting]

Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast« [Recruiting]

Study Comparing Full-Dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid

Zoledronic Acid in the Prevention of Skeletal-Related Events in Hormone Refractory and Hormone-Sensitive Prostate Cancer Patients With Bone Metastases [Completed]

Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients [Recruiting]

Assessment of the Efficacy, Tolerability and Pharmaco-Economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone Metastasis [Active, not recruiting]

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer [Recruiting]

Open-Label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. [Withdrawn]

Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions [Recruiting]

A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can Be Treated With a Group of Medications Known as Bisphosphonates [Completed]

To Assess the Efficacy of Over-the-Counter Analgesics in the Prevention/Treatment of Transient Post-Dose Symptoms Following Zoledronate Infusion in Post-Menopausal Women [Completed]

A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate [Completed]

Adjuvant Docetaxel-Zoledronic Acid in High-Risk Early Prostate Cancer Following Prostatectomy. [Terminated]

Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-Symptomatic Bone Lesions [Terminated]

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone [No longer recruiting]

Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone [Completed]

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density [Active, not recruiting]

Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms [No longer recruiting]

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer [No longer recruiting]

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases [No longer recruiting]

Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole [Recruiting]

Imatinib Mesylate and Zoledronic Acid in Patients With Chronic Myeloid Leukaemia in Cytogenetic Response Without Molecular Response [Not yet recruiting]

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma [Recruiting]

Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer [Recruiting]

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders [Recruiting]

Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions [No longer recruiting]

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014